Psiquiatras podrían adoptar biomarcadores en el diagnóstico de la salud mental
En un documento de enero, la Asociación Americana de Psiquiatría incluyó ideas sobre cómo podría incorporar biomarcadores —indicadores biológicos de enfermedad mental que pueden aparecer en pruebas diagnósticas— en futuras versiones de su Manual Diagnóstico y Estadístico de los Trastornos Mentales.
Psychiatrists’ Use of Biomarkers Could Open a New Window Into Mental Health Diagnoses
The world’s largest professional psychiatry organization is preparing for the day when biological indicators can help diagnose and treat mental illness.
As Insurers Struggle With GLP-1 Drug Costs, Some Seek To Wean Patients Off
Conventional wisdom says GLP-1 drugs must be taken indefinitely to maintain weight loss. But a growing number of researchers, payers, and providers are challenging that consensus and exploring whether — and how — to taper patients off expensive GLP-1 drugs.
